News on Cluster_Headache_Headache from BioPortfolio.com http://www.BioPortfolio.com Consolidated Cluster_Headache_Headache news from BioPortfolio.com Wed, 10 Feb 2010 10:49:39 GMT en Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headachehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039766&HITNO=0&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039766&THISHREF=http://c.moreover.com/click/here.pl%3fz2538372432%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039766&HITNO=0&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039766&THISHREF=http://c.moreover.com/click/here.pl%3fz2538372432%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headachehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039695&HITNO=1&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039695&THISHREF=http://c.moreover.com/click/here.pl%3fz2538328842%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039695&HITNO=1&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039695&THISHREF=http://c.moreover.com/click/here.pl%3fz2538328842%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headachehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039632&HITNO=2&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039632&THISHREF=http://c.moreover.com/click/here.pl%3fz2538271178%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039632&HITNO=2&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039632&THISHREF=http://c.moreover.com/click/here.pl%3fz2538271178%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: TI commences Phase IIa clinical trial for its lead molecule in CDHhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039877&HITNO=3&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039877&THISHREF=http://c.moreover.com/click/here.pl%3fz2538446081%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039877&HITNO=3&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039877&THISHREF=http://c.moreover.com/click/here.pl%3fz2538446081%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Diabetes Q&A: What Clues Help Distinguish Type 1 From Type 2 Diabetes?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027827&HITNO=4&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027827&THISHREF=http://c.moreover.com/click/here.pl%3fz2532386446%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027827&HITNO=4&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027827&THISHREF=http://c.moreover.com/click/here.pl%3fz2532386446%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comConsultant Live: Kidney Damage in Earthquake Crush Victims may be Prevented by Headache Pillhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026729&HITNO=5&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026729&THISHREF=http://c.moreover.com/click/here.pl%3fz2531214859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026729&HITNO=5&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026729&THISHREF=http://c.moreover.com/click/here.pl%3fz2531214859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedIndia: Aradigm's first U.S. sale of SUMAVEL DosePro needle-free delivery system triggers $4M milestone paymenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019011&HITNO=6&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019011&THISHREF=http://c.moreover.com/click/here.pl%3fz2526058113%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019011&HITNO=6&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019011&THISHREF=http://c.moreover.com/click/here.pl%3fz2526058113%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL DoseProhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018737&HITNO=7&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018737&THISHREF=http://c.moreover.com/click/here.pl%3fz2525911498%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018737&HITNO=7&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018737&THISHREF=http://c.moreover.com/click/here.pl%3fz2525911498%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Focusing on Depression in Expectant and New Fathershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020203&HITNO=8&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020203&THISHREF=http://c.moreover.com/click/here.pl%3fz2526638694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020203&HITNO=8&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020203&THISHREF=http://c.moreover.com/click/here.pl%3fz2526638694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comConsultant Live: Acanthosis Nigricanshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019618&HITNO=9&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019618&THISHREF=http://c.moreover.com/click/here.pl%3fz2526397954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019618&HITNO=9&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019618&THISHREF=http://c.moreover.com/click/here.pl%3fz2526397954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comConsultant Live: Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL DoseProhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016718&HITNO=10&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016718&THISHREF=http://c.moreover.com/click/here.pl%3fz2524853339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016718&HITNO=10&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016718&THISHREF=http://c.moreover.com/click/here.pl%3fz2524853339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL* DosePro*http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013624&HITNO=11&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013624&THISHREF=http://c.moreover.com/click/here.pl%3fz2523782995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013624&HITNO=11&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013624&THISHREF=http://c.moreover.com/click/here.pl%3fz2523782995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL* DosePro*http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012812&HITNO=12&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012812&THISHREF=http://c.moreover.com/click/here.pl%3fz2523530273%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012812&HITNO=12&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012812&THISHREF=http://c.moreover.com/click/here.pl%3fz2523530273%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL* DosePro*http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012732&HITNO=13&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012732&THISHREF=http://c.moreover.com/click/here.pl%3fz2523507058%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012732&HITNO=13&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012732&THISHREF=http://c.moreover.com/click/here.pl%3fz2523507058%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Headache in cerebral venous thrombosis: incidence, pattern and location in 200 consecutive patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003899&HITNO=14&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003899&THISHREF=http://c.moreover.com/click/here.pl%3fz2519728219%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003899&HITNO=14&MSIZE=100&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cluster_Headache_Headache&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003899&THISHREF=http://c.moreover.com/click/here.pl%3fz2519728219%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: